Boswellia Serrata 333mg | 40% Boswellic Acids | Joint Pain and Osteoarthritis Relief | 90 Vegan Capsules
Each vegan capsule delivers 333mg of Boswellia serrata trunk bark oleogum resin extract, standardized to 40% boswellic acids (approximately 133mg boswellic acids per capsule), in a 4.003:1 concentrate providing QCE 1.333g of raw resin per capsule.
Helps to relieve joint pain and swelling associated with osteoarthritis of the knee. Health Canada licensed NPN 80075731. Use for a minimum of 2 months to see beneficial effects. Made in Canada. 90 vegan capsules, 30 day supply at 3 capsules per day.
Source
Botanical source: Boswellia serrata, a moderate to large branching tree native to dry mountainous regions of India (family Burseraceae). Known in Ayurvedic medicine as Shallaki, used for centuries for joint and inflammatory health support.
Plant part: Trunk bark oleogum resin, the same type of resin used as frankincense in religious and cultural ceremonies. The resin is tapped from the trunk bark when it is cut or injured.
Standardization: 40% boswellic acids by weight of extract, verified by batch testing.
Concentration: 4.003:1 extract ratio | QCE 1.333g raw resin per 333mg capsule | QCE approximately 4g per daily dose of 3 capsules.
What Is Boswellia Serrata?
Boswellia serrata is the Indian species of Boswellia, a tree native to dry mountainous regions of India. It produces an oleogum resin from its trunk bark that has been used in Ayurvedic medicine for centuries under the name Shallaki for joint and inflammatory health support. The trunk bark oleogum resin is the source of boswellic acids, the primary bioactive compounds in Boswellia serrata extract. This formula uses a 4.003:1 concentrated extract standardized to 40% boswellic acids, the most extensively researched form of Boswellia for osteoarthritis of the knee.
What Are Boswellic Acids and Which Is Most Active?
Boswellic acids are a family of pentacyclic triterpene acids found in the resin of Boswellia species. The major boswellic acids in Boswellia serrata include beta-boswellic acid, acetyl-beta-boswellic acid, 11-keto-beta-boswellic acid (KBA), and acetyl-11-keto-beta-boswellic acid (AKBA). AKBA is considered the most pharmacologically active, primarily through inhibition of 5-lipoxygenase (5-LOX), the enzyme responsible for leukotriene synthesis. This formula is standardized to 40% total boswellic acids, ensuring consistent potency across every batch.
Key Benefits
- Helps to relieve joint pain and swelling associated with osteoarthritis of the knee Health Canada licensed claim under NPN 80075731
- 333mg Boswellia serrata extract per capsule Standardized to 40% boswellic acids | Approximately 133mg boswellic acids per capsule
- 4.003:1 concentrate QCE 1.333g raw trunk bark oleogum resin per capsule | QCE approximately 4g per daily dose of 3 capsules
- Source: Boswellia serrata trunk bark oleogum resin, India Ayurvedic botanical used for centuries as Shallaki
- Only 2 non-medicinal ingredients Magnesium stearate and hypromellose | Nothing else
- Vegan capsule Hypromellose shell, no gelatin or animal derived ingredients
- Health Canada licensed NPN 80075731 | GMP certified | Made in Canada
- 90 vegan capsules 30 day supply at 3 capsules per day | Minimum 2 bottles for the licensed 2-month trial period
Important: Minimum 2 Months of Use Required
The Health Canada licensed duration of use for this formula is a minimum of 2 months to see beneficial effects. Boswellia serrata is not a fast-acting analgesic. It works over time with consistent daily use. At 3 capsules per day, 90 capsules provides a 30 day supply. A minimum of 2 bottles is required to complete the licensed 2-month trial period.
How It Works
Boswellic Acids and 5-Lipoxygenase Inhibition
The primary mechanism of boswellic acids, particularly AKBA, is inhibition of 5-lipoxygenase (5-LOX), the enzyme that converts arachidonic acid to leukotrienes. Leukotrienes are pro-inflammatory lipid mediators that contribute to joint inflammation and swelling. By inhibiting 5-LOX, boswellic acids reduce leukotriene synthesis, supporting a healthy inflammatory response in joint tissue. This mechanism is distinct from NSAIDs (which inhibit COX enzymes) and from corticosteroids, making Boswellia a complementary option for joint health support.
Why Standardization to 40% Boswellic Acids Matters
Raw Boswellia resin varies significantly in boswellic acid content depending on the tree, harvest season, and processing method. Standardization to 40% boswellic acids means every batch of this extract is tested and verified to contain at least 40% boswellic acids by weight, ensuring consistent potency and reproducible results. At 333mg extract per capsule, each capsule contains approximately 133mg of boswellic acids. Per daily dose of 3 capsules: approximately 399mg of boswellic acids.
Why 3 Capsules Per Day in Divided Doses
The recommended dose is 1 capsule 3 times per day rather than 3 capsules at once. Dividing the daily dose maintains more consistent boswellic acid levels throughout the day, which is consistent with the dosing approach used in clinical research on Boswellia serrata for osteoarthritis of the knee.
Understanding the Extract Ratio and QCE
The 4.003:1 extract ratio means 4.003 grams of raw Boswellia serrata trunk bark oleogum resin were used to produce 1 gram of standardized extract. QCE (Quantity of Crude Equivalent) is the Health Canada standardized notation for expressing the raw material equivalent of a concentrated herbal extract. Each 333mg capsule provides QCE 1.333g of raw resin. At 3 capsules per day, the daily dose provides QCE approximately 4g of raw resin.
Medicinal Ingredient (per capsule)
- Boswellia (Boswellia serrata, trunk bark oleogum resin) 333mg Source: Indian Boswellia serrata trunk bark oleogum resin | Standardized to 40% boswellic acids (approximately 133mg per capsule) | 4.003:1 concentrate | QCE 1.333g | Helps to relieve joint pain and swelling associated with osteoarthritis of the knee | NPN 80075731
Non-medicinal ingredients: Magnesium stearate, hypromellose (vegetable capsule shell). Gluten free. Soy free. Dairy free. Non-GMO.
Per Daily Dose (3 Capsules)
- Boswellia serrata extract: 999mg
- Boswellic acids (40%): approximately 399mg
- Raw resin equivalent (QCE): approximately 4g
Quality and Trust
- NPN 80075731 Licensed by Health Canada as a Natural Health Product
- Made in Canada GMP certified facility under Health Canada oversight
- Standardized to 40% boswellic acids Batch-tested for consistent potency
- 4.003:1 concentrate QCE 1.333g raw resin per capsule
- Only 2 non-medicinal ingredients Magnesium stearate and hypromellose
- Vegan capsule Hypromellose shell, no gelatin or animal derived ingredients
- Gluten free, soy free, dairy free, non-GMO
- 90 vegan capsules 30 day supply at 3 capsules per day
Who This Is For
- Consult a healthcare practitioner before use if you are pregnant or breastfeeding
- If symptoms worsen, consult a healthcare practitioner
- Discontinue use if hypersensitivity or allergy occurs, or if you experience gastrointestinal disturbances such as diarrhea, abdominal pain, heartburn, nausea, or vomiting
- Adults seeking a Health Canada licensed Boswellia serrata extract for joint pain and swelling associated with osteoarthritis of the knee
- Those who want a high-potency, standardized boswellic acid formula with only 2 non-medicinal ingredients
- Adults committed to a minimum 2-month consistent daily use protocol as required by the licensed duration of use
How to Use
Adults: Take 1 capsule, 3 times per day, with or without food. Use for a minimum of 2 months to see beneficial effects.
At 3 capsules per day, 90 capsules provides a 30 day supply. A minimum of 2 bottles is required for the licensed 2-month trial period.
Safety and Cautions
Consult a healthcare practitioner before use if you are pregnant or breastfeeding. If symptoms worsen, consult a healthcare practitioner. Hypersensitivity (e.g. allergy) has been known to occur; discontinue use if it occurs. Some people may experience mild gastrointestinal disturbances such as diarrhea, abdominal pain, heartburn, nausea, or vomiting; discontinue use if this occurs. Store in a cool, dry place away from direct sunlight and moisture. Keep bottle tightly sealed. Do not use if the seal is broken or missing. Keep out of reach of children.
NPN 80075731. This product is not intended to diagnose, treat, cure, or prevent any disease. All health claims are consistent with Health Canada's Natural Health Products Regulations.
Boswellia Serrata 333mg | 40% Boswellic Acids | Joint Pain and Osteoarthritis Relief | 90 Vegan Capsules
Each vegan capsule delivers 333mg of Boswellia serrata trunk bark oleogum resin extract, standardized to 40% boswellic acids (approximately 133mg boswellic acids per capsule), in a 4.003:1 concentrate providing QCE 1.333g of raw resin per capsule.
Helps to relieve joint pain and swelling associated with osteoarthritis of the knee. Health Canada licensed NPN 80075731. Use for a minimum of 2 months to see beneficial effects. Made in Canada. 90 vegan capsules, 30 day supply at 3 capsules per day.
Source
Botanical source: Boswellia serrata, a moderate to large branching tree native to dry mountainous regions of India (family Burseraceae). Known in Ayurvedic medicine as Shallaki, used for centuries for joint and inflammatory health support.
Plant part: Trunk bark oleogum resin, the same type of resin used as frankincense in religious and cultural ceremonies. The resin is tapped from the trunk bark when it is cut or injured.
Standardization: 40% boswellic acids by weight of extract, verified by batch testing.
Concentration: 4.003:1 extract ratio | QCE 1.333g raw resin per 333mg capsule | QCE approximately 4g per daily dose of 3 capsules.
What Is Boswellia Serrata?
Boswellia serrata is the Indian species of Boswellia, a tree native to dry mountainous regions of India. It produces an oleogum resin from its trunk bark that has been used in Ayurvedic medicine for centuries under the name Shallaki for joint and inflammatory health support. The trunk bark oleogum resin is the source of boswellic acids, the primary bioactive compounds in Boswellia serrata extract. This formula uses a 4.003:1 concentrated extract standardized to 40% boswellic acids, the most extensively researched form of Boswellia for osteoarthritis of the knee.
What Are Boswellic Acids and Which Is Most Active?
Boswellic acids are a family of pentacyclic triterpene acids found in the resin of Boswellia species. The major boswellic acids in Boswellia serrata include beta-boswellic acid, acetyl-beta-boswellic acid, 11-keto-beta-boswellic acid (KBA), and acetyl-11-keto-beta-boswellic acid (AKBA). AKBA is considered the most pharmacologically active, primarily through inhibition of 5-lipoxygenase (5-LOX), the enzyme responsible for leukotriene synthesis. This formula is standardized to 40% total boswellic acids, ensuring consistent potency across every batch.
Key Benefits
- Helps to relieve joint pain and swelling associated with osteoarthritis of the knee Health Canada licensed claim under NPN 80075731
- 333mg Boswellia serrata extract per capsule Standardized to 40% boswellic acids | Approximately 133mg boswellic acids per capsule
- 4.003:1 concentrate QCE 1.333g raw trunk bark oleogum resin per capsule | QCE approximately 4g per daily dose of 3 capsules
- Source: Boswellia serrata trunk bark oleogum resin, India Ayurvedic botanical used for centuries as Shallaki
- Only 2 non-medicinal ingredients Magnesium stearate and hypromellose | Nothing else
- Vegan capsule Hypromellose shell, no gelatin or animal derived ingredients
- Health Canada licensed NPN 80075731 | GMP certified | Made in Canada
- 90 vegan capsules 30 day supply at 3 capsules per day | Minimum 2 bottles for the licensed 2-month trial period
Important: Minimum 2 Months of Use Required
The Health Canada licensed duration of use for this formula is a minimum of 2 months to see beneficial effects. Boswellia serrata is not a fast-acting analgesic. It works over time with consistent daily use. At 3 capsules per day, 90 capsules provides a 30 day supply. A minimum of 2 bottles is required to complete the licensed 2-month trial period.
How It Works
Boswellic Acids and 5-Lipoxygenase Inhibition
The primary mechanism of boswellic acids, particularly AKBA, is inhibition of 5-lipoxygenase (5-LOX), the enzyme that converts arachidonic acid to leukotrienes. Leukotrienes are pro-inflammatory lipid mediators that contribute to joint inflammation and swelling. By inhibiting 5-LOX, boswellic acids reduce leukotriene synthesis, supporting a healthy inflammatory response in joint tissue. This mechanism is distinct from NSAIDs (which inhibit COX enzymes) and from corticosteroids, making Boswellia a complementary option for joint health support.
Why Standardization to 40% Boswellic Acids Matters
Raw Boswellia resin varies significantly in boswellic acid content depending on the tree, harvest season, and processing method. Standardization to 40% boswellic acids means every batch of this extract is tested and verified to contain at least 40% boswellic acids by weight, ensuring consistent potency and reproducible results. At 333mg extract per capsule, each capsule contains approximately 133mg of boswellic acids. Per daily dose of 3 capsules: approximately 399mg of boswellic acids.
Why 3 Capsules Per Day in Divided Doses
The recommended dose is 1 capsule 3 times per day rather than 3 capsules at once. Dividing the daily dose maintains more consistent boswellic acid levels throughout the day, which is consistent with the dosing approach used in clinical research on Boswellia serrata for osteoarthritis of the knee.
Understanding the Extract Ratio and QCE
The 4.003:1 extract ratio means 4.003 grams of raw Boswellia serrata trunk bark oleogum resin were used to produce 1 gram of standardized extract. QCE (Quantity of Crude Equivalent) is the Health Canada standardized notation for expressing the raw material equivalent of a concentrated herbal extract. Each 333mg capsule provides QCE 1.333g of raw resin. At 3 capsules per day, the daily dose provides QCE approximately 4g of raw resin.
Medicinal Ingredient (per capsule)
- Boswellia (Boswellia serrata, trunk bark oleogum resin) 333mg Source: Indian Boswellia serrata trunk bark oleogum resin | Standardized to 40% boswellic acids (approximately 133mg per capsule) | 4.003:1 concentrate | QCE 1.333g | Helps to relieve joint pain and swelling associated with osteoarthritis of the knee | NPN 80075731
Non-medicinal ingredients: Magnesium stearate, hypromellose (vegetable capsule shell). Gluten free. Soy free. Dairy free. Non-GMO.
Per Daily Dose (3 Capsules)
- Boswellia serrata extract: 999mg
- Boswellic acids (40%): approximately 399mg
- Raw resin equivalent (QCE): approximately 4g
Quality and Trust
- NPN 80075731 Licensed by Health Canada as a Natural Health Product
- Made in Canada GMP certified facility under Health Canada oversight
- Standardized to 40% boswellic acids Batch-tested for consistent potency
- 4.003:1 concentrate QCE 1.333g raw resin per capsule
- Only 2 non-medicinal ingredients Magnesium stearate and hypromellose
- Vegan capsule Hypromellose shell, no gelatin or animal derived ingredients
- Gluten free, soy free, dairy free, non-GMO
- 90 vegan capsules 30 day supply at 3 capsules per day
Who This Is For
- Consult a healthcare practitioner before use if you are pregnant or breastfeeding
- If symptoms worsen, consult a healthcare practitioner
- Discontinue use if hypersensitivity or allergy occurs, or if you experience gastrointestinal disturbances such as diarrhea, abdominal pain, heartburn, nausea, or vomiting
- Adults seeking a Health Canada licensed Boswellia serrata extract for joint pain and swelling associated with osteoarthritis of the knee
- Those who want a high-potency, standardized boswellic acid formula with only 2 non-medicinal ingredients
- Adults committed to a minimum 2-month consistent daily use protocol as required by the licensed duration of use
How to Use
Adults: Take 1 capsule, 3 times per day, with or without food. Use for a minimum of 2 months to see beneficial effects.
At 3 capsules per day, 90 capsules provides a 30 day supply. A minimum of 2 bottles is required for the licensed 2-month trial period.
Safety and Cautions
Consult a healthcare practitioner before use if you are pregnant or breastfeeding. If symptoms worsen, consult a healthcare practitioner. Hypersensitivity (e.g. allergy) has been known to occur; discontinue use if it occurs. Some people may experience mild gastrointestinal disturbances such as diarrhea, abdominal pain, heartburn, nausea, or vomiting; discontinue use if this occurs. Store in a cool, dry place away from direct sunlight and moisture. Keep bottle tightly sealed. Do not use if the seal is broken or missing. Keep out of reach of children.
NPN 80075731. This product is not intended to diagnose, treat, cure, or prevent any disease. All health claims are consistent with Health Canada's Natural Health Products Regulations.